Request for Information (RFI) on the National Institutes of Health Plan to Develop the Genetic Testing Registry; Notice, 39699 [2010-16904]

Download as PDF Federal Register / Vol. 75, No. 132 / Monday, July 12, 2010 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 6, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–16903 Filed 7–9–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings erowe on DSK5CLS3C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Digestive Diseases and Nutrition Mentored Applications Review. Date: July 28, 2010. Time: 2 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Lakshmanan Sankaran, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7799, ls38z@nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, NIDDK Ancillary Research. Date: July 30, 2010. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. VerDate Mar<15>2010 14:19 Jul 09, 2010 Jkt 220001 39699 Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Thomas A. Tatham, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 760, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Translational Research. Date: September 14, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Michele L. Barnard, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) outlined in this RFI, may submit comments by e-mail to GTR@od.nih.gov or by mail to the following address: NIH GTR RFI Comments, National Institutes of Health, Office of Science Policy, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892. Comments will be made publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. FOR FURTHER INFORMATION CONTACT: Cathy Fomous, PhD, NIH Office of Biotechnology Activities, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892; telephone 301–496–9838; fax 301–496–9839; e-mail CFomous@od.nih.gov. Dated: July 6, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [Docket No. FDA–2004–F–0069] (formerly Docket No. 2004F–0455) [FR Doc. 2010–16900 Filed 7–9–10; 8:45 am] Dated: July 7, 2010. Raynard S. Kington, Deputy Director, National Institutes of Health. [FR Doc. 2010–16904 Filed 7–9–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Sterigenics International, Inc.; Withdrawal of Food Additive Petition AGENCY: BILLING CODE 4140–01–P Food and Drug Administration, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information (RFI) on the National Institutes of Health Plan to Develop the Genetic Testing Registry; Notice On June 11, 2010, the National Institutes of Health (NIH), an agency within the Department of Health and Human Services (HHS), published a Request for Information (RFI) on its plan to develop a voluntary Genetic Testing Registry (GTR), a centralized public resource that will provide information about the availability, scientific basis, and usefulness of genetic tests (see Vol. 75, No. 112, page 33317). The NIH is extending the comment period for the RFI from July 12, 2010, to August 2, 2010. A copy of the RFI is also available at https://www.ncbi.nlm.nih.gov/gtr/. DATES: To ensure consideration, comments must now be received by August 2, 2010. ADDRESSES: Individuals, groups, and organizations interested in commenting on the NIH plan to develop the GTR, as PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the withdrawal, without prejudice to a future filing, of a food additive petition (FAP 3M4744) proposing that the food additive regulations be amended to provide for the safe use of ionizing radiation in the production of shelf stable foods, including multiple ingredient shelf stable foods. FOR FURTHER INFORMATION CONTACT: Lane A. Highbarger, Center for Food Safety and Applied Nutrition (HFS– 255), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740–3835, 301–436–1204. SUPPLEMENTARY INFORMATION: In a notice published in the Federal Register of November 30, 2004 (69 FR 69606), FDA announced that a food additive petition (FAP 3M4744) had been filed by Sterigenics International, Inc., P.O. Box 17349, Memphis, TN 31817–0349 (current address 2015 Spring Rd., suite 650, Oak Brook, IL 60523). The petition proposed to amend the food additive regulations in 21 CFR part 179 Irradiation in the Production, Processing and Handling of Food to provide for the E:\FR\FM\12JYN1.SGM 12JYN1

Agencies

[Federal Register Volume 75, Number 132 (Monday, July 12, 2010)]
[Notices]
[Page 39699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-16904]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information (RFI) on the National Institutes of 
Health Plan to Develop the Genetic Testing Registry; Notice

    On June 11, 2010, the National Institutes of Health (NIH), an 
agency within the Department of Health and Human Services (HHS), 
published a Request for Information (RFI) on its plan to develop a 
voluntary Genetic Testing Registry (GTR), a centralized public resource 
that will provide information about the availability, scientific basis, 
and usefulness of genetic tests (see Vol. 75, No. 112, page 33317). The 
NIH is extending the comment period for the RFI from July 12, 2010, to 
August 2, 2010. A copy of the RFI is also available at https://www.ncbi.nlm.nih.gov/gtr/.

DATES: To ensure consideration, comments must now be received by August 
2, 2010.

ADDRESSES: Individuals, groups, and organizations interested in 
commenting on the NIH plan to develop the GTR, as outlined in this RFI, 
may submit comments by e-mail to GTR@od.nih.gov or by mail to the 
following address: NIH GTR RFI Comments, National Institutes of Health, 
Office of Science Policy, 6705 Rockledge Drive, Room 750, Bethesda, MD 
20892. Comments will be made publicly available, including any 
personally identifiable or confidential business information that they 
contain. Trade secrets should not be submitted.

FOR FURTHER INFORMATION CONTACT: Cathy Fomous, PhD, NIH Office of 
Biotechnology Activities, 6705 Rockledge Drive, Room 750, Bethesda, MD 
20892; telephone 301-496-9838; fax 301-496-9839; e-mail 
CFomous@od.nih.gov.

    Dated: July 7, 2010.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 2010-16904 Filed 7-9-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.